As telecoms networks continue to expand their services, what even counts as a strategic investment these days? A selection of industry figures tell Global Venturing it can include Web3, ESG and 5G-related technologies.

Telefónica Ventures head of investments Pablo Moro tells Global Venturing Web3 and the metaverse are now among its priorities, with play-to-earn, tokenisation, VR and AR among the potential strategic areas.

Pfizer Ventures has hired Irena Melnikova, formerly CFO of Umoja Biopharma and MD of SVB Leerink, as an executive director.

Invest in a business development function — early. Be creative with funding and careful with how your strategic value is measured.

Pfizer Ventures has led a $102m series A for Capstan Therapeutics while Globis Capital Partners took part in an $85.4m round for Andpad.

Danilo Gaspar has been hired by the Brazilian medical education and digital health tool provider as head of corporate venture capital.

Access Industries, Pfizer and SR One were among the investors in a $125m round for Nimbus Therapeutics while Aerwins agreed a reverse takeover.

Masaji Matsuoka has left Mistui & Co after more than 12 years and joined Magenta Venture Partners as managing general director.

David Clouse, a GCV Emerging Leader this year while at BP Ventures, will lead EIC Rose Rock, a $50m fund backed by Devon Energy, Onoek and Williams.

Senior investment director Karim Chehadé has announced his departure from Experian Ventures' strategic investment vehicle, three months after colleague Chan Yip Pang.